2S3.F
APA Corporation
FrankfurtEUREQUITY
Energy
DELAYED
Last price
37.73
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
37.73
Day high
37.73
Day low
37.73
Volume
350
Market cap
$13.22B
P/E (TTM)
9.29
52W range
18.38 – 39.90
Trailing performance
Returnvs SPY
1W
+9.49%
+10.9%
1M
+17.16%
+13.4%
3M
+15.90%
+12.8%
6M
+55.41%
+44.3%
YTD
+83.44%
+71.2%
1Y
+112.27%
+92.3%
3Y
-3.85%
-78.0%
5Y
+136.15%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2S3.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.55M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | JOUNG CHANSOO Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | STOVER DAVID L Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | RAGAUSS PETER A Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | FISHER KENNETH M Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | BAY ANNELL R Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | ELLIS JULIET S. Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | MCKAY LAMAR Director |
STOCK | 2.30K | $0 | Direct |
| Jun 30, 26 | HOOPER CHARLES W. Director |
STOCK | 1.53K | $0 | Direct |
| Jun 30, 26 | WEAVING ANYA Director |
STOCK | 1.53K | $0 | Direct |
| May 26, 26 | HENDERSON TRACEY K Officer |
— | 5.00K | — | Direct |
| Mar 31, 26 | JOUNG CHANSOO Director |
STOCK | 1.18K | $0 | Direct |
| Mar 31, 26 | STOVER DAVID L Director |
STOCK | 1.18K | $0 | Direct |
| Mar 31, 26 | RAGAUSS PETER A Director |
STOCK | 1.18K | $0 | Direct |
| Mar 31, 26 | FISHER KENNETH M Director |
STOCK | 1.18K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAY ANNELL R |
Director | 103.72K | Stock Award(Grant) |
BRETCHES D. CLAY |
Officer | 63.84K | Conversion of Exercise of derivative security |
CHRISTMANN JOHN J IV |
Chief Executive Officer | 857.91K | Stock Gift |
ELLIS JULIET S. |
Director | 89.32K | Stock Award(Grant) |
HOYT REBECCA A |
Officer | 116.86K | Conversion of Exercise of derivative security |
JOUNG CHANSOO |
Director | 244.74K | Stock Award(Grant) |
MADDOX MARK D |
Officer | 81.45K | Conversion of Exercise of derivative security |
MCKAY LAMAR |
Director | 55.70K | Stock Award(Grant) |
RAGAUSS PETER A |
Director | 101.86K | Stock Award(Grant) |
RINEY STEPHEN J |
President | 310.83K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$13.22B
Enterprise value$17.58B
Revenue (TTM)$8.57B
Gross profit$6.71B
EBITDA$5.72B
Net income$1.68B
EPS (TTM)$4.06
Free cash flow$2.15B
Total cash$444.00M
Total debt$3.88B
Book value / share$17.13
Shares outstanding350.35M
Float348.13M
Short % of float—
Dividend yield2.27%
Beta (5Y)0.35
Valuation & profitability ratios
Trailing P/E9.29
Forward P/E12.05
PEG ratio0.83
Price / sales—
Price / book2.20
EV / revenue2.05
EV / EBITDA3.07
Gross margin78.25%
Operating margin56.33%
Profit margin19.56%
Return on equity26.66%
Return on assets11.60%
Debt / equity48.85
Current ratio0.95
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.92B | $9.74B | $8.28B | $11.07B | -8.4% |
| Operating revenue | $8.92B | $9.74B | $8.28B | $11.07B | -8.4% |
| Cost of revenue | $5.30B | $5.43B | $4.05B | $4.82B | -2.4% |
| Gross profit | $3.62B | $4.30B | $4.23B | $6.25B | -15.9% |
| Selling, general & admin | $350.00M | $372.00M | $351.00M | $483.00M | -5.9% |
| Total operating expense | $868.00M | $1.10B | $869.00M | $1.17B | -21.3% |
| Operating income | $2.75B | $3.20B | $3.36B | $5.08B | -14.0% |
| Net interest income | -$260.00M | -$367.00M | -$321.00M | -$312.00M | +29.2% |
| Pre-tax income | $2.79B | $1.53B | $2.88B | $5.73B | +81.8% |
| Tax provision | $1.10B | $417.00M | -$324.00M | $1.65B | +163.5% |
| Net income | $1.43B | $804.00M | $2.85B | $3.60B | +78.4% |
| Net income to common | $1.43B | $804.00M | $2.85B | $3.67B | +78.4% |
| Basic EPS | 3.99 | 2.28 | 9.26 | 11.05 | +75.0% |
| Diluted EPS | 3.99 | 2.27 | 9.25 | 11.02 | +75.8% |
| EBIT | $3.07B | $1.91B | $3.21B | $6.05B | +60.8% |
| EBITDA | $5.37B | $4.17B | $4.75B | $7.28B | +28.7% |
| Basic shares | 359.00M | 353.00M | 308.00M | 332.00M | +1.7% |
| Diluted shares | 359.00M | 353.00M | 309.00M | 333.00M | +1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $516.00M | $625.00M | $87.00M | $245.00M | -17.4% |
| Cash & short-term investments | $516.00M | $625.00M | $87.00M | $245.00M | -17.4% |
| Accounts receivable | $1.06B | $1.96B | $1.61B | $1.47B | -45.8% |
| Inventory | $351.00M | $425.00M | $453.00M | $427.00M | -17.4% |
| Total current assets | $2.12B | $3.40B | $2.46B | $2.71B | -37.7% |
| Property, plant & equipment | $12.75B | $12.65B | $10.04B | $9.01B | +0.8% |
| Total assets | $17.76B | $19.39B | $15.24B | $13.15B | -8.4% |
| Total current liabilities | $2.57B | $2.96B | $2.40B | $2.92B | -13.0% |
| Current debt | $213.00M | $53.00M | $2.00M | $2.00M | +301.9% |
| Long-term debt | $4.28B | $5.99B | $5.19B | $5.45B | -28.6% |
| Total debt | $4.59B | $6.16B | $5.30B | $5.62B | -25.5% |
| Total liabilities | $10.76B | $13.03B | $11.55B | $11.80B | -17.4% |
| Retained earnings | -$721.00M | -$2.15B | -$2.96B | -$5.81B | +66.5% |
| Shareholder equity | $6.09B | $5.28B | $2.65B | $423.00M | +15.4% |
| Working capital | -$450.00M | $449.00M | $58.00M | -$208.00M | -200.2% |
| Net tangible assets | $6.09B | $5.28B | $2.65B | $423.00M | +15.4% |
| Shares issued | 492.04M | 491.58M | 420.60M | 419.87M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.69B | $1.12B | $3.21B | $4.08B | — | +51.3% |
| Change in working capital | $292.00M | -$535.00M | -$417.00M | $121.00M | — | +154.6% |
| Operating cash flow | $4.54B | $3.62B | $3.13B | $4.94B | — | +25.6% |
| Capital expenditure | -$2.77B | -$2.91B | -$2.36B | -$2.40B | — | +5.0% |
| Investing cash flow | -$2.15B | -$924.00M | -$2.14B | -$1.51B | — | -133.0% |
| Share buybacks | — | — | -$329.00M | -$1.42B | -$847.00M | — |
| Dividends paid | -$360.00M | -$353.00M | -$308.00M | -$207.00M | — | -2.0% |
| Financing cash flow | -$2.50B | -$2.16B | -$1.15B | -$3.49B | — | -15.9% |
| Free cash flow | $1.78B | $709.00M | $772.00M | $2.54B | — | +150.9% |
| End cash position | $516.00M | $625.00M | $87.00M | $245.00M | — | -17.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $2.37B | $2.33B | $1.99B | $2.12B | $2.18B | — | +2.0% |
| Operating revenue | $2.37B | $2.33B | $1.99B | $2.12B | $2.18B | — | +2.0% |
| Cost of revenue | $822.00M | $1.08B | $1.13B | $1.24B | $1.30B | — | -24.0% |
| Gross profit | $1.55B | $1.25B | $857.00M | $880.00M | $873.00M | — | +24.5% |
| Selling, general & admin | $68.00M | $115.00M | $91.00M | $95.00M | $66.00M | — | -40.9% |
| Total operating expense | $230.00M | $239.00M | $217.00M | $208.00M | $202.00M | — | -3.8% |
| Operating income | $1.32B | $1.01B | $640.00M | $672.00M | $671.00M | — | +31.2% |
| Net interest income | -$54.00M | -$57.00M | -$58.00M | -$48.00M | -$69.00M | — | +5.3% |
| Pre-tax income | $1.28B | $830.00M | $489.00M | $511.00M | $1.03B | — | +53.9% |
| Tax provision | $450.00M | $287.00M | $158.00M | $233.00M | $363.00M | — | +56.8% |
| Net income | $747.00M | $446.00M | $279.00M | $205.00M | $603.00M | — | +67.5% |
| Net income to common | $747.00M | $446.00M | $279.00M | $205.00M | $603.00M | — | +67.5% |
| Basic EPS | 2.11 | 1.26 | 0.79 | — | 1.67 | 0.96 | +67.5% |
| Diluted EPS | 2.11 | 1.26 | 0.79 | — | 1.67 | 0.96 | +67.5% |
| EBIT | $1.33B | $886.00M | $550.00M | $571.00M | $1.10B | — | +50.1% |
| EBITDA | $1.83B | $1.44B | $1.12B | $1.14B | $1.63B | — | +27.4% |
| Basic shares | 353.00M | 354.00M | 355.00M | — | 361.00M | 364.00M | -0.3% |
| Diluted shares | 354.00M | 354.00M | 355.00M | — | 361.00M | 364.00M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $444.00M | $293.00M | $516.00M | $475.00M | $107.00M | +51.5% |
| Cash & short-term investments | $444.00M | $293.00M | $516.00M | $475.00M | $107.00M | +51.5% |
| Accounts receivable | $1.22B | $1.46B | $1.06B | $1.01B | $1.51B | -16.1% |
| Inventory | $371.00M | $334.00M | $351.00M | $361.00M | $386.00M | +11.1% |
| Total current assets | $2.28B | $2.29B | $2.12B | $1.97B | $2.29B | -0.5% |
| Property, plant & equipment | $12.90B | $12.82B | $12.75B | $12.72B | $12.64B | +0.6% |
| Total assets | $17.97B | $18.08B | $17.76B | $17.70B | $18.08B | -0.6% |
| Total current liabilities | $2.41B | $2.49B | $2.57B | $2.54B | $2.84B | -3.4% |
| Current debt | $2.00M | $134.00M | $213.00M | $213.00M | $263.00M | -98.5% |
| Long-term debt | $3.74B | $4.28B | $4.28B | $4.28B | $4.29B | -12.6% |
| Total debt | $3.88B | $4.54B | $4.59B | $4.59B | $4.66B | -14.4% |
| Total liabilities | $10.03B | $10.68B | $10.76B | $10.84B | $11.18B | -6.1% |
| Retained earnings | $384.00M | -$275.00M | -$721.00M | -$1.00B | -$1.21B | +239.6% |
| Shareholder equity | $7.02B | $6.46B | $6.09B | $5.96B | $5.91B | +8.8% |
| Working capital | -$130.00M | -$202.00M | -$450.00M | -$572.00M | -$556.00M | +35.6% |
| Net tangible assets | $7.02B | $6.46B | $6.09B | $5.96B | $5.91B | +8.8% |
| Shares issued | 350.67M | 492.52M | 492.04M | 492.03M | 492.03M | -28.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $827.00M | $543.00M | $331.00M | $278.00M | $665.00M | +52.3% |
| Change in working capital | $198.00M | -$637.00M | -$224.00M | $271.00M | $200.00M | +131.1% |
| Operating cash flow | $1.71B | $554.00M | $808.00M | $1.46B | $1.18B | +207.9% |
| Capital expenditure | -$571.00M | -$546.00M | -$590.00M | -$719.00M | -$667.00M | -4.6% |
| Investing cash flow | -$591.00M | -$542.00M | -$572.00M | -$700.00M | -$95.00M | -9.0% |
| Dividends paid | -$89.00M | -$88.00M | -$89.00M | -$90.00M | -$90.00M | -1.1% |
| Financing cash flow | -$964.00M | -$235.00M | -$195.00M | -$392.00M | -$1.05B | -310.2% |
| Free cash flow | $1.14B | $8.00M | $218.00M | $741.00M | $514.00M | +14,087.5% |
| End cash position | $444.00M | $293.00M | $516.00M | $475.00M | $107.00M | +51.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $2.11B | +4.6% |
| Next quarter | — | — | $2.11B | +6.7% |
| Current year | — | — | $8.84B | -4.1% |
| Next year | — | — | $7.89B | -10.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.44%
Held by institutions109.23%
Institutions holding1.08K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.40
+6.58% from price
SMA 20
33.31
+13.26% from price
SMA 50
31.12
+21.24% from price
SMA 100
31.83
+18.52% from price
SMA 200
27.89
+35.24% from price
EMA 12
35.10
+7.48% from price
EMA 26
33.42
+12.89% from price
EMA 50
32.29
+16.81% from price
RSI (14)
70.6
Overbought
MACD (12,26,9)
1.68
Hist 0.49
ATR (14)
0.89
2.37% of price
Realised vol 30D
51.2%
Annualised
Bollinger upper
38.16
20, 2σ
Bollinger lower
28.46
20, 2σ
50 / 200 cross
Golden
31.12 vs 27.89
Trend bias
Above 200
+35.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.47
Less volatile than market
Correlation to SPY
-0.11
Largely independent
Realised vol 30D
51.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.2%
Peak to trough
Max drawdown 5Y
-75.2%
Peak to trough
ATR 14
0.89
2.37% of price
Beta (reported)
0.35
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 19, 26 | Argus Research | UPGRADE | Hold | Buy |
| Aug 17, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 13, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 12, 26 | Benchmark | MAINTAINED | Buy | Buy |
| Aug 11, 26 | Susquehanna | MAINTAINED | Positive | Positive |
| Aug 10, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 21, 26 | Susquehanna | MAINTAINED | Positive | Positive |
| Jul 15, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 13, 26 | Raymond James | MAINTAINED | Outperform | Outperform |
| Jul 10, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jun 29, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
Dividends & splits
Forward rate$0.86 / yr
Forward yield2.27%
5-year avg yield2.71%
Payout ratio21.10%
Ex-dividend dateJul 22, 2026
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2023-05-04
Periodic Financial Reports
10-K · 2023-02-23
Periodic Financial Reports
10-Q · 2022-11-03
Periodic Financial Reports
10-Q · 2022-08-04
Periodic Financial Reports
10-Q · 2022-05-05
Corporate Changes & Voting Matters
8-K · 2022-05-02
Corporate Changes & Voting Matters
8-K · 2022-03-14
Periodic Financial Reports
10-K · 2022-02-22
Headlines
TME Pharma provides update on its activities
GlobeNewswire · 10m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 15m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 15m ago
Board Update
GlobeNewswire · 15m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 15m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 15m ago
Holding(s) in Company
GlobeNewswire · 15m ago
Summary of AB KN Energies webinar
GlobeNewswire · 15m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.